About the journal
Фармакоэкономика is an open-access journal published by IRBIS LLC in Russia, publishing in russian. It is listed in DOAJ according to the sources read. Declared publication charge: 15,000 RUB. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- IRBIS LLC
- ISSN
- 2070-4909 · 2070-4933
- Country
- Russia
- Languages
- russian
- Access
- Open access
- Declared publication charge
- 15,000 RUB
- Articles in DOAJ
- 544
- Declared review time
- 8 weeks
- Declared peer-review model
- double_blind
- Official website
- https://www.pharmacoeconomics.ru/jour
Index listings
- DOAJ · 2019-06-04
- Indexing
- DOAJ
- APC
- 15,000 RUB
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
544
Most recent article
3 months ago
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
493
Last recorded publication year
2026
h-index
15
i10-index
29
From OpenAlex open data (CC0).
Editorial & policy9
- Last DOAJ review date
- 2022-10-23
- Added to DOAJ
- 2019-06-04
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 100%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- Peer-review policy
- View policy
Identity & continuity2
- Alternate titles
- Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiologyPharmacoeconomicsFarmakoèkonomika. Sovremennaâ farmakoèkonomika i farmakoèpidemiologiâ
- Source type
- journal
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Healthcare Systems and Public Health
- Healthcare Systems and Public Health
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Economic, Social, and Public Health Issues in Russia and Globally
- Economic, Social, and Public Health Issues in Russia and Globally
Show all subjects (50)
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Respiratory and Cough-Related Research
- Respiratory and Cough-Related Research
- Artificial Intelligence in Healthcare and Education
- Human Health and Disease
- Human Health and Disease
- Computational Drug Discovery Methods
- Artificial Intelligence in Healthcare and Education
- Computational Drug Discovery Methods
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Asthma and respiratory diseases
- Neurological Disorders and Treatments
- Neurological Disorders and Treatments
- Asthma and respiratory diseases
- Osteoarthritis Treatment and Mechanisms
- Diet, Metabolism, and Disease
- Health and Medical Research Impacts
- Inflammatory mediators and NSAID effects
- Diet, Metabolism, and Disease
- Health and Medical Research Impacts
- Inflammatory mediators and NSAID effects
- Cutaneous Melanoma Detection and Management
- Liver Disease Diagnosis and Treatment
- Osteoarthritis Treatment and Mechanisms
- Cutaneous Melanoma Detection and Management
- Liver Disease Diagnosis and Treatment
- Diabetes Treatment and Management
- Diabetes Treatment and Management
- COVID-19 Clinical Research Studies
- Healthcare cost, quality, practices
- Biosimilars and Bioanalytical Methods
- Medical and Agricultural Research Studies
- Biosimilars and Bioanalytical Methods
- Healthcare cost, quality, practices
- COVID-19 Clinical Research Studies
- Medical and Agricultural Research Studies
- Economic and Technological Developments in Russia
- Economic and Technological Developments in Russia
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
Keywords (DOAJ)
- pharmacoepidemiology
- pharmacoeconomics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ